Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS, Green JB, Buse JB, Inzucchi SE, Leiter LA et al..  2018.  Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Editors' Expert Forum. Diabetes Care. 41(1):14-31.

Zhang YM, Zimmer MA, Guardia T, Callahan SJ, Mondal C, Di Martino J, Takagi T, Fennell M, Garippa R, Campbell NR et al..  2018.  Distant Insulin Signaling Regulates Vertebrate Pigmentation through the Sheddase Bace2.. Dev Cell. 45(5):580-594.e7.

Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D, Amadiume SC, Goncalves MD, Hodakoski C, Lundquist MR et al..  2018.  Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.. Nature. 560(7719):499-503.

Vazirani RP, Verma A, L Sadacca A, Buckman MS, Picatoste B, Beg M, Torsitano C, Bruno JH, Patel RT, Simonyte K et al..  2016.  Disruption of Adipose Rab10-Dependent Insulin Signaling Causes Hepatic Insulin Resistance.. Diabetes. 65(6):1577-89.

O'Donnell PE, Ye XZhen, DeChellis MA, Davis VM, Duan SZhong, Mortensen RM, Milstone DS.  2016.  Lipodystrophy, Diabetes and Normal Serum Insulin in PPARγ-Deficient Neonatal Mice.. PLoS One. 11(8):e0160636.

Harris KK, Zopey M, Friedman TC.  2016.  Metabolic effects of smoking cessation.. Nat Rev Endocrinol. 12(5):299-308.